115615-66-2

Upstream product

• 3068-32-4 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl-a-D-galactopyranoside 
• 13992-26-2 (2R,3S,4S,5R,6R)-2-(acetoxymethyl)-6-azidotetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 115615-64-0 Boc-Tyr-DMet-Gly-Phe-OH 
• 1148-11-4 N-Benzyloxycarbonyl-L-proline 
• 41355-50-4 2,3,4,6-tetra-O-acetyl-D-glucosyl-1-amine 
• 66863-93-2 N-(t-butoxycarbonyl)-L-tyrosyl-D-methionyl-glycyl-L-phenylalanyl-L-proline 
• 72829-60-8 Boc Tyr D_.Met Gly Phe Pro OMe 
• 41355-50-4 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosylamine 
• 122350-58-7 N-benzyloxycarbonyl 1-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl> proline 

Downstream Products

• 113282-21-6 (D-Met²,Pro⁵)-enkephalin-N-(galactopyranosyl)amide 

Relevant academic research and scientific papers

SYNTHESIS OF A NEW SERIES OF ENKEPHALIN RELATED GALACTOSYL CONJUGATES

(D-Met2,Pro5)-enkephalin-N-(β-D-galactopyranosyl)amide, a glycopeptide containing a galactose residue at the C-terminal position of the μ-selective enkaphalin analogue (D-Met2,Pro5)-enkaphalinamide, has been syn

THE INCORPORATION OF SUGAR MOIETIES TO NEUROPEPTIDES; COMPARATIVE STUDY OF DIFFERENT METHODS

By using both β-N-glycosylation and β-O-glycosylation procedures, different methods for the incorporation of glucose moieties to proline, hydroxyproline or glutamic acid containing protected neuropeptides have been examined.As far as glycosylation of Glu